| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 71.60B | 73.14B | 86.80B | 82.55B | 82.82B | 80.68B |
| Gross Profit | 23.03B | 21.89B | 29.41B | 29.69B | 27.54B | 26.78B |
| EBITDA | 24.84B | 32.81B | 37.76B | 38.18B | 33.87B | 34.41B |
| Net Income | 9.44B | 9.51B | 10.81B | 10.72B | 9.96B | 9.76B |
Balance Sheet | ||||||
| Total Assets | 528.51B | 506.24B | 425.40B | 415.25B | 409.02B | 399.99B |
| Cash, Cash Equivalents and Short-Term Investments | 25.39B | 20.84B | 16.79B | 15.58B | 14.84B | 15.83B |
| Total Debt | 300.03B | 279.79B | 199.34B | 207.29B | 206.42B | 210.49B |
| Total Liabilities | 348.76B | 328.08B | 253.08B | 249.95B | 251.09B | 249.08B |
| Stockholders Equity | 125.50B | 123.24B | 119.44B | 113.24B | 107.03B | 100.91B |
Cash Flow | ||||||
| Free Cash Flow | -6.45B | -2.06B | 18.35B | 18.87B | 19.53B | 20.47B |
| Operating Cash Flow | 33.17B | 31.11B | 38.02B | 33.12B | 31.37B | 34.91B |
| Investing Cash Flow | -39.70B | -33.05B | -20.17B | -12.51B | -14.38B | -14.57B |
| Financing Cash Flow | 12.59B | 6.14B | -17.97B | -19.09B | -20.90B | -17.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | HK$75.61B | 3.92 | 12.54% | 5.62% | -2.05% | 96.13% | |
68 Neutral | HK$99.76B | 6.06 | 12.76% | 5.89% | -3.11% | -5.45% | |
66 Neutral | HK$117.50B | 5.19 | 11.62% | 4.74% | -6.95% | 61.55% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
64 Neutral | HK$63.90B | 6.33 | 9.76% | 5.73% | 12.74% | 6.35% | |
61 Neutral | HK$245.37B | 14.39 | 7.98% | 3.50% | -16.49% | -5.62% | |
58 Neutral | HK$119.20B | 11.02 | 6.01% | 5.33% | -13.95% | -25.30% |